What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
Xavier Montalban focuses on Multiple sclerosis, Internal medicine, Surgery, Expanded Disability Status Scale and Magnetic resonance imaging.
He works in the field of Multiple sclerosis, namely Clinically isolated syndrome.
His Clinically isolated syndrome research includes themes of McDonald criteria and Optic neuritis.
The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Placebo and Placebo-controlled study.
His study looks at the relationship between Surgery and fields such as Fingolimod, as well as how they intersect with chemical problems.
His Magnetic resonance imaging research includes elements of Longitudinal study, Predictive value of tests, Cerebrospinal fluid and Treatment response.
His most cited work include:
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria (7085 citations)
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis (1970 citations)
- Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. (1666 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Multiple sclerosis, Internal medicine, Immunology, In patient and Clinically isolated syndrome.
His study of Expanded Disability Status Scale is a part of Multiple sclerosis.
His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology, Placebo, Ocrelizumab and Oncology.
His biological study spans a wide range of topics, including Clinical endpoint, Adverse effect and Phases of clinical research.
His research on Clinically isolated syndrome often connects related topics like McDonald criteria.
His research in Surgery is mostly concerned with Central nervous system disease.
He most often published in these fields:
- Multiple sclerosis (75.00%)
- Internal medicine (34.38%)
- Immunology (21.43%)
What were the highlights of his more recent work (between 2017-2021)?
- Multiple sclerosis (75.00%)
- Internal medicine (34.38%)
- In patient (18.64%)
In recent papers he was focusing on the following fields of study:
Multiple sclerosis, Internal medicine, In patient, Clinical trial and Ocrelizumab are his primary areas of study.
His work deals with themes such as Magnetic resonance imaging, Disease and Intensive care medicine, which intersect with Multiple sclerosis.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology, Placebo and Oncology.
His studies deal with areas such as Observational study and Randomized controlled trial as well as Clinical trial.
His study looks at the relationship between Ocrelizumab and topics such as Disability progression, which overlap with Relapse rate.
The study incorporates disciplines such as McDonald criteria, Proportional hazards model and Brain size in addition to Clinically isolated syndrome.
Between 2017 and 2021, his most popular works were:
- ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis: (199 citations)
- ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. (67 citations)
- Multiple sclerosis: clinical aspects. (65 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Gene
Xavier Montalban mostly deals with Multiple sclerosis, Internal medicine, Expanded Disability Status Scale, Clinical trial and In patient.
His Multiple sclerosis research focuses on Clinically isolated syndrome in particular.
His Clinically isolated syndrome research is multidisciplinary, relying on both McDonald criteria, Proportional hazards model, Cohort study and Cohort.
His Internal medicine research incorporates themes from Gastroenterology, Placebo and Ocrelizumab.
His research integrates issues of Patient satisfaction, Clinical endpoint and Physical therapy in his study of Expanded Disability Status Scale.
His work in Clinical trial tackles topics such as Randomized controlled trial which are related to areas like Interferon beta-1a, Placebo-controlled study, Myeloid cells, Tyrosine kinase and Bruton's tyrosine kinase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
